I was really impressed by the size and quality of the Drug Discovery 2014 organised by ELRIG in Manchester. More than 1,500 scientists participated in this meeting and nearly 100 exhibitors were present. Phentoypic screening and high content screening were prominent in this conference and we could hear researchers from Roche, Astrazeneca, Merck Serono or Cancer research UK / UK-NPSC (National Screening Phentypic center) to explain us how they have implemented phenotypic screening and HCA / HCS in their lab and process of drug discovery.
Here, you can hear an interesting interview from Dr. Peter Simpson, Co-Organizer of Elrig Drug Discovery 2014, directed by SelectScience :

Dr. Peter Simpson Discusses ELRIG Drug Discovery 2014

Dr. Peter Simpson Discusses ELRIG Drug Discovery 2014


0 Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.